Sull'Impiego Del Ceftazidime Nelle Infezioni Di Pazienti Nefropatici a Rischio Infettivo Elevato

Acred P. , Ryan D. M. , Sowa M. A. , Watts C. M. : The in vivo antibacterial activity of Ceftazidime (GR 20263). A comparison with other new beta-lactam antibiotics and Gentamicin. J. Antimicrob. Chemother., 8; suppl. B, 247–255 (1981).

Acred P. , Harding S. M. , Ryan D. M. : The in vivo properties of GR 20263 (Ceftazidime). A highly active broad spectrum cephalosporin with high antipseudomonal activity. Drugs Exptl. Clin. Res., 7; 189–199 (1981).

Concia E. , Ugazio A. G. , Carbonera D. , Dionigi R. : Studio aperto sull'efficacia, sicurezza e tollerabilità del Ceftazidime nel trattamento di infezioni batteriche gravi. Simp. Intern. Glaxo: Il Ceftazidime, Roma 11–12 Nov. 1983.

Foord R. D. , Paton A. M. : Aspetti dell'efficacia e della tollerabilità del Ceftazidime. Simp. Intern. Glaxo: Il Ceftazidime, Roma 11–12 Nov. 1983.

Harper P. B. , Kirby S. M. : The in vitro properties of GR 20263. A highly active broad spectrum cephalosporin with anipseudomonal activity. Drugs Exptl. Clin. Res., 7; 179–187 (1981).

Harris A. M. , Plested S. G. , Harper P. B. : A comparison of the in vitro properties of Ceftazidime with those of new broad spectrum cephalosporins and gentamicin. J. Antimicrob. Chemother., 8; suppl. B, 43–45 (1981).

Jones R. N. : In vitro quantitative evaluation of Ceftazidime compared with Cefamandole, Gentamicin and other antimicrobics. A collaborative (four medical centers) study of 7435 clinical isolates and other special organism populations, p. 505–508 in: Periti P. , Gialdroni-Grassi G. : Current chemotherapy and immunotherapy. Proc. 12 I.C.C., Florence 19–24 July, 1981. Amer. Soc. Microbiol., p. 1585, Washington 1982.

Knothe H. , Dette G. A. : The in vitro activity of Ceftazidime against clinically important pathogens. J. Antimicrob. Chemother., 8; suppl. B, 33–41 (1981).

Nicoletti P. , Lamanna S. : Valutazione dell'attività in vitro del Ceftazidime. Simp. Intern. Glaxo: Il Ceftazidime, Roma 11–12 Nov. 1983.

O'Callaghan C. H. : GR 20263, a new broad spectrum cephalosporin with antipseudomonal activity. Antimicrob. Agents Chemother., 17; 876–883 (1980).

Schassan H. H. , Fedder J. : Activity of Ceftazidime and newer antibiotics against Gram-negative bacilli. J. Antimicrob. Chemother., 8; suppl. B, 79–82 (1981).

Soncini R. , Fostini R. : Ceftazidime (RG 159): breve profilo micriobiologico, farmacologico e clinico. Biol. Med., 5; 277–286 (1983).

Von Graevenitz A. , Bucher C. : The effect of N-formimidoylthienamycin, Ceftazidime, Cefotiam, Ceftriaxone and Cefotaxime on non fermentative Gram-negative rods, aeromonas, plesiomonas and enterobacter agglomerans. Infection, 10; 293–298 (1982).